Cargando…
A mechanism of IL-34-induced resistance against cytotoxic anti-cancer therapies such as radiation by X-ray and chemotherapy by Oxaliplatin
Interleukin-34 (IL-34) has been known as a factor that is involved with tumor progression and therapeutic resistance. However, there are limitations to addressing the mechanism of how IL-34 induces therapeutic resistance. Here, we show a mechanism of IL-34-induced resistance against cytotoxic anti-c...
Autores principales: | Han, Nanumi, Wada, Haruka, Kobayashi, Takuto, Otsuka, Ryo, Seino, Ken-Ichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10392724/ https://www.ncbi.nlm.nih.gov/pubmed/37533702 http://dx.doi.org/10.1080/2162402X.2023.2238499 |
Ejemplares similares
-
An optimized protocol for patient-derived xenograft in humanized mice to evaluate the role of IL-34 in immunotherapeutic resistance
por: Han, Nanumi, et al.
Publicado: (2021) -
Enhanced IL-34 expression in Nivolumab-resistant metastatic melanoma
por: Han, Nanumi, et al.
Publicado: (2018) -
Interleukin-34 cancels anti-tumor immunity by PARP inhibitor
por: Nakamura, Takayoshi, et al.
Publicado: (2022) -
Bromodomain-containing protein 4 regulates interleukin-34 expression in mouse ovarian cancer cells
por: Han, Nanumi, et al.
Publicado: (2020) -
Interleukin-34 Limits the Therapeutic Effects of Immune Checkpoint Blockade
por: Hama, Naoki, et al.
Publicado: (2020)